A phase I study of MEDI4736, NNT-PD-L1 antibody in patients with advanced solid tumors

Por Zielinski, Christoph C.
Publicado no Transl Lung Cancer Res (2014)

ESMO Open—Cancer Horizons and the future of oncology

Por Zielinski, Christoph C
Publicado no ESMO Open (2016)

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

Por Zielinski, Christoph C, Pinto, Carmine
Publicado no ESMO Open (2016)

CSCO joins ESMO Open—Cancer Horizons

Por Zielinski, Christoph C, Wu, Yi-Long
Publicado no ESMO Open (2016)

Cancer immune cycle: a video introduction to the interaction between cancer and the immune system

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph C
Publicado no ESMO Open (2016)

Drugs for HER-2-positive breast cancer

Por Sibilia, Maria., Zielinski, Christoph C., Bartsch, Rupert., Grunt, Thomas W.
Publicado em 2011

Angiogenesis in cancer: Anti-VEGF escape mechanisms

Por Prager, Gerald W., Poettler, Marina, Unseld, Matthias, Zielinski, Christoph C.
Publicado no Transl Lung Cancer Res (2012)

CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior

Por Poettler, Marina, Unseld, Matthias, Braemswig, Kira, Haitel, Andrea, Zielinski, Christoph C, Prager, Gerald W
Publicado em 2013

A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma)

Por Kiesewetter, Barbara, Troch, Marlene, Dolak, Werner, Müllauer, Leonhard, Lukas, Julius, Zielinski, Christoph C., Raderer, Markus
Publicado em 2013

Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease

Por Kieler, Markus, Scheithauer, Werner, Zielinski, Christoph C, Chott, Andreas, Al-Mukhtar, Ali, Prager, Gerald W
Publicado no ESMO Open (2016)

A phase II study of bortezomib in patients with MALT lymphoma

Por Troch, Marlene, Jonak, Constanze, Müllauer, Leonhard, Püspök, Andreas, Formanek, Michael, Hauff, Wolfgang, Zielinski, Christoph C., Chott, Andreas, Raderer, Markus
Publicado em 2009

Influence of the American ODAC Statement on Austrian Bevacizumab Prescribing Practice for Metastatic Breast Cancer

Por Preusser, Matthias, Fülöp, Gerhard, Berghoff, Anna Sophie, Heinzl, Harald, Steger, Guenther G., Greil, Richard, Zielinski, Christoph C., Bartsch, Rupert
Publicado em 2012

Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer

Por Gampenrieder, Simon P., Bartsch, Rupert, Matzneller, Peter, Pluschnig, Ursula, Dubsky, Peter, Gnant, Michael X., Zielinski, Christoph C., Steger, Guenther G.
Publicado em 2010

“Il flauto magico” still works: Mozart’s secret of ventilation

Por Laczika, Klaus, Graber, Oliver P, Tucek, Gerhard, Lohninger, Alfred, Fliri, Nikolaus, Berka-Schmid, Gertraud, Masel, Eva K, Zielinski, Christoph C
Publicado em 2013

Indocyanine Green Video Angiography Predicts Outcome of Extravasation Injuries

Por Haslik, Werner, Pluschnig, Ursula, Steger, Günther G., Zielinski, Christoph C., Schrögendorfer, K. F., Nedomansky, Jakob, Bartsch, Rupert, Mader, Robert M.
Publicado em 2014

Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel

Por Bartsch, Rupert, Steger, Guenther G, Forstner, Birgit, Wenzel, Catharina, Pluschnig, Ursula, Rizovski, Blanka, Altorjai, Gabriela, Zielinski, Christoph C, Mader, Robert M
Publicado em 2007

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

Por Prager, Gerald W, Braemswig, Kira H, Martel, Alexandra, Unseld, Matthias, Heinze, Georg, Brodowicz, Thomas, Scheithauer, Werner, Kornek, Gabriela, Zielinski, Christoph C
Publicado no Cancer Sci (2014)

Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

Por Schulenburg, Axel, Blatt, Katharina, Cerny-Reiterer, Sabine, Sadovnik, Irina, Herrmann, Harald, Marian, Brigitte, Grunt, Thomas W, Zielinski, Christoph C, Valent, Peter
Publicado no J Hematol Oncol (2015)

Nab-paclitaxel as alternative treatment regimen in advanced cholangiocellular carcinoma

Por Unseld, Matthias, Scheithauer, Werner, Weigl, Roman, Kornek, Gabriela, Stranzl, Nadja, Bianconi, Daniela, Brunauer, Georg, Steger, Guenther, Zielinski, Christoph C., Prager, Gerald W.
Publicado no J Gastrointest Oncol (2016)

Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment

Por Bartsch, Rupert, Wenzel, Catharina, Pluschnig, Ursula, Hussian, Dagmar, Sevelda, Ursula, Altorjai, Gabriela, Locker, Gottfried J, Mader, Robert, Zielinski, Christoph C, Steger, Guenther G
Publicado em 2006